Clinical Trial Update: Investigation of the Biomarker Copeptin in Patients With Acute Myocardial Infarction

View source ↗

Summary

The clinical trial evaluated the biomarker copeptin in patients with acute myocardial infarction and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction

Snippet

Sponsor: Brahms AG | Conditions: Acute Coronary Syndromes | Status: COMPLETED